Matches in Nanopublications for { ?s ?p "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434919.RAu1IJmMPJfwJDQ_HjLUayQmgm6OiES0mivvxTT6zgPcQ130_provenance.
- NP375183.RAtdiNB8bHPeHxtAXmCSTrMSlLb_76hVoQD9ma3xIqf1w130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375183.RAtdiNB8bHPeHxtAXmCSTrMSlLb_76hVoQD9ma3xIqf1w130_provenance.
- NP760392.RA11O-eBsoTi2C0mpFDuxNLOONzgLScJdp0vGaiH8q7Js130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760392.RA11O-eBsoTi2C0mpFDuxNLOONzgLScJdp0vGaiH8q7Js130_provenance.
- NP832493.RAd9vYX9tY10GsqHnpw99ZWFrYt8bUe4DGyyCiui3LMeM130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832493.RAd9vYX9tY10GsqHnpw99ZWFrYt8bUe4DGyyCiui3LMeM130_provenance.
- assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP868106.RAk1cHL1vzj4eFK_fRnGnImMJoaP5ka6sEoA7n13niDtk130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868106.RAk1cHL1vzj4eFK_fRnGnImMJoaP5ka6sEoA7n13niDtk130_provenance.
- NP868117.RAv3LOBJFngd2SmkEbBiKE5_aT6LXA3RYX7UydghRmYuY130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868117.RAv3LOBJFngd2SmkEbBiKE5_aT6LXA3RYX7UydghRmYuY130_provenance.
- NP867197.RAR_DCMTOLIFYAQEQHL2yr-ieUnqumDFeYW1PLIpBCo-Q130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867197.RAR_DCMTOLIFYAQEQHL2yr-ieUnqumDFeYW1PLIpBCo-Q130_provenance.
- NP867201.RAkHoOgGYiyAIsWfsikMIB4xI4Ugx7iBl6APIsOZJJZY8130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867201.RAkHoOgGYiyAIsWfsikMIB4xI4Ugx7iBl6APIsOZJJZY8130_provenance.
- NP867202.RAgBbT6b0p5ZtUZIDIwAkpfp7Vl4sIUbQ8KUgjf7vu79Y130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867202.RAgBbT6b0p5ZtUZIDIwAkpfp7Vl4sIUbQ8KUgjf7vu79Y130_provenance.
- NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832506.RAGSMIeZSbPwbVJ8636R1IO9n3Ah0pptRN6I-65nRNu0g130_provenance.
- NP867198.RAxsbsLdsC234Dtrj3PIZ7Ts3mBWs_v0kgvliCJ9HlX5I130_assertion description "[Mutations in the gene mitofusin 2 (MFN2) cause the axonal subtype CMT2A, which has also been shown to be associated with optic atrophy, clinical signs of first motor neuron involvement, and early onset stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867198.RAxsbsLdsC234Dtrj3PIZ7Ts3mBWs_v0kgvliCJ9HlX5I130_provenance.